-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, A3O+I7Gu2lQTeyqvbClbukTcLYmnwDVoPgkXN36fRuSEyn/N1i5y2ZdXMGVzusDB RRBcUL+lMIIWoBTZhutMkQ== 0001179110-11-003304.txt : 20110223 0001179110-11-003304.hdr.sgml : 20110223 20110223190417 ACCESSION NUMBER: 0001179110-11-003304 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20110218 FILED AS OF DATE: 20110223 DATE AS OF CHANGE: 20110223 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: YOUNG WILLIAM D CENTRAL INDEX KEY: 0001217420 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-30319 FILM NUMBER: 11633640 MAIL ADDRESS: STREET 1: C/O VAXGEN INC STREET 2: 1000 MARINA BLVD. #200 CITY: BRISBANE STATE: CA ZIP: 94005 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: THERAVANCE INC CENTRAL INDEX KEY: 0001080014 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 943265960 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 901 GATEWAY BLVD CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 BUSINESS PHONE: 6508086000 MAIL ADDRESS: STREET 1: 901 GATEWAY BLVD CITY: S. SAN FRANCISCO STATE: CA ZIP: 94080 FORMER COMPANY: FORMER CONFORMED NAME: ADVANCED MEDICINE INC DATE OF NAME CHANGE: 20000302 4 1 edgar.xml FORM 4 - X0303 4 2011-02-18 0 0001080014 THERAVANCE INC THRX 0001217420 YOUNG WILLIAM D THERAVANCE, INC. 901 GATEWAY BOULEVARD SOUTH SAN FRANCISCO CA 94080 1 0 0 0 Common Stock 2011-02-18 4 M 0 10752 8.525 A 34129 D Common Stock 2011-02-18 4 S 0 5376 23.22 D 28753 D Stock Option (Right to Buy) 8.525 2011-02-18 4 M 0 10752 0 D 2011-04-07 Common Stock 10752 10752 D This transaction was executed in multiple trades at prices ranging from $23.08 to $23.68. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares and prices at which the transaction was effected. Immediately exercisable. Dispositions made pursuant to a plan intended to comply with Rule 10b5-1(c). William D. Young 2011-02-23 -----END PRIVACY-ENHANCED MESSAGE-----